129 related articles for article (PubMed ID: 805036)
41. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
42. The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and pentaerythritol tetranitrate.
Russek HI
Am J Med Sci; 1966 Jul; 252(1):9-20. PubMed ID: 4957459
[No Abstract] [Full Text] [Related]
43. [Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients].
Zharov EI; Sal'nikov SN; Vertkin AL
Kardiologiia; 1987 Feb; 27(2):41-6. PubMed ID: 3106696
[TBL] [Abstract][Full Text] [Related]
44. Coronary heart disease. Hemodynamic response to exercise before and after nitroglycerin.
Di Giorgi S; West RO; Parker JO
Mal Cardiovasc; 1968; 9(1):29-50. PubMed ID: 4981691
[No Abstract] [Full Text] [Related]
45. [Therapy of angina pectoris. II. Evaluation of antianginous drugs. Nitrites and nitrates].
Messini M
Clin Ter; 1974 Jan; 68(2):105-36. PubMed ID: 4207505
[No Abstract] [Full Text] [Related]
46. A ten-year reevaluation. Nitroglycerin and isosorbide dinitrate in coronary insufficiency.
Leslie RE
Tex Med; 1971 Nov; 67(11):95-8. PubMed ID: 5001168
[No Abstract] [Full Text] [Related]
47. Nitrate tolerance: does tid isosorbide dinitrate mean dosing every eight hours?
O'Quinn SV; Figg WD
DICP; 1991 Nov; 25(11):1272-3. PubMed ID: 1763550
[No Abstract] [Full Text] [Related]
48. [The effect of five different long-acting nitroglycerine derivatives on angina pectoris].
Kaltenbach M; Tiedemann I; Schellhorn W
Dtsch Med Wochenschr; 1972 Oct; 97(40):1479-84. PubMed ID: 4627249
[No Abstract] [Full Text] [Related]
49. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
Kayali A
Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
[No Abstract] [Full Text] [Related]
50. [Conservative therapy of angina pectoris].
Nager F
Schweiz Med Wochenschr; 1970 May; 100(20):855-61. PubMed ID: 4997632
[No Abstract] [Full Text] [Related]
51. [Therapeutic experiences with viskenit (LBI-45) in ischemic heart disease and symptoms of angina pectoris].
Ripka O; Chvatíková J
Med Monatsschr; 1977 Jun; 31(6):281-3. PubMed ID: 20565
[TBL] [Abstract][Full Text] [Related]
52. [Possibility of developing tolerance to the anti-anginal effect of isosorbide dinitrate and verapamil].
Metelitsa VI; Shakarova SSh; Martsevich SIu; Vygodin VA; Strel'tsov AA
Kardiologiia; 1985 Jan; 25(1):63-7. PubMed ID: 3920428
[TBL] [Abstract][Full Text] [Related]
53. Drugs for prophylaxis of angina pectoris.
Med Lett Drugs Ther; 1975 Jul; 17(14):57-8. PubMed ID: 805906
[No Abstract] [Full Text] [Related]
54. Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris.
Aronow WS; Kaplan MA
N Engl J Med; 1969 Apr; 280(16):847-50. PubMed ID: 4975605
[No Abstract] [Full Text] [Related]
55. Can the problem of nitrate tolerance be solved?
Silber S
Z Kardiol; 1985; 74 Suppl 1():51-4. PubMed ID: 3993162
[No Abstract] [Full Text] [Related]
56. [2. International Symposium on Nitrates; Berlin 1-3 June 1978. Nitrate-effect on the heart and circulation].
Fortschr Med; 1978 Sep; 96(36):1792-6. PubMed ID: 100402
[No Abstract] [Full Text] [Related]
57. Effectiveness of sustained-action isosorbide dinitrate on exercise-induced myocardial ischemia.
Brunner D; Meshulam N; Zerieker F
Chest; 1974 Sep; 66(3):282-7. PubMed ID: 4607776
[No Abstract] [Full Text] [Related]
58. The use of isosorbide dinitrate in status anginosus.
Semler HJ
Curr Ther Res Clin Exp; 1970 Dec; 12(12):789-93. PubMed ID: 4994683
[No Abstract] [Full Text] [Related]
59. [Vasodilatation as a therapeutic principle in the treatment of angina pectoris and recent heart infarct].
Behrenbeck DW; Tauchert M; Hötzel J; Jansen W; Niehues B; Hilger HH
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():203-6. PubMed ID: 417501
[No Abstract] [Full Text] [Related]
60. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
